Literature DB >> 15217953

Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.

Sanjeewani T Palayoor1, Melissa A Burgos, Azadeh Shoaibi, Philip J Tofilon, C Norman Coleman.   

Abstract

PURPOSE: Tumor hypoxia is a major limiting factor for radiation therapy. Hypoxia-inducible factors (HIFs) are overexpressed in several human cancers and are considered prognostic markers and potential targets for cancer therapy. The purpose of the present study was to investigate the impact of HIFs on radiosensitivity. EXPERIMENTAL
DESIGN: Renal clear cell carcinoma (RCC) cell lines overexpressing HIFs under normoxic conditions because of inactivation of von Hippel-Lindau tumor suppressor gene function (VHL-ve) and their matched pairs in which overexpression of HIFs was abolished by expression of functional VHL (VHL+ve) were irradiated. Radiosensitivity was determined by clonogenic assay. HIF and VHL protein levels were evaluated by Western blot analysis. RCC cells were also treated with ibuprofen, a radiosensitizer and HIF inhibitor in prostate cancer cells. The effect of ibuprofen on radiosensitization and HIF and VHL proteins was compared in RCC matched-pair cell lines.
RESULTS: The data showed only small differences in the radiosensitivity between the cells overexpressing HIFs and cells with basal HIF levels. The dose-modifying factors for C2, 786-0, and A498 RCC cells were 1.14, 1.14 and 1.15, respectively. Radiation did not alter HIF or VHL protein levels. Ibuprofen inhibited HIFs in VHL+ve cells expressing basal levels of HIFs. In VHL-ve cells overexpressing HIFs, the inhibition was very modest. Ibuprofen radiosensitized C2 RCC cells to the same extent irrespective of their HIF status.
CONCLUSIONS: Overexpression of HIFs in RCC cells harboring VHL mutations has only a modest effect on the radiosensitivity. Radiosensitization by ibuprofen appears to be independent of HIF status.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15217953     DOI: 10.1158/1078-0432.CCR-04-0005

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  11 in total

1.  Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects.

Authors:  Sanjeewani T Palayoor; Molykutty J-Aryankalayil; Adeola Y Makinde; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  J Cardiovasc Pharmacol       Date:  2012-06       Impact factor: 3.105

2.  A new hypoxia inducible factor-2 inhibitory pyrrolinone alkaloid from roots and stems of Piper sarmentosum.

Authors:  Heidi Rose Bokesch; Roberta Scott Gardella; Daniel Christopher Rabe; Donald Paul Bottaro; William Marston Linehan; James Brislin McMahon; Tawnya Carlene McKee
Journal:  Chem Pharm Bull (Tokyo)       Date:  2011       Impact factor: 1.645

3.  Enzyme-linked immunosorbent assay for pharmacological studies targeting hypoxia-inducible factor 1alpha.

Authors:  J L Formento; E Berra; B Ferrua; N Magné; G Simos; C Brahimi-Horn; J Pouysségur; G Milano
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

4.  miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.

Authors:  Murali Gururajan; Sajni Josson; Gina Chia-Yi Chu; Chia-Lun Lu; Yi-Tsung Lu; Christopher L Haga; Haiyen E Zhau; Chunyan Liu; Jake Lichterman; Peng Duan; Edwin M Posadas; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2014-10-16       Impact factor: 12.531

5.  microRNAs and Prostate Cancer.

Authors:  Sajni Josson; Leland W K Chung; Murali Gururajan
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

6.  PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells.

Authors:  Sanjeewani T Palayoor; James B Mitchell; David Cerna; William Degraff; Molykutty John-Aryankalayil; C Norman Coleman
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

7.  Hypoxia-inducible factor-2alpha: effect on radiation sensitivity and differential regulation by an mTOR inhibitor.

Authors:  Rupal S Bhatt; Daniel M Landis; Michael Zimmer; Joelle Torregrossa; Shaoyong Chen; Vikas P Sukhatme; Othon Iliopoulos; Steve Balk; Glenn J Bubley
Journal:  BJU Int       Date:  2008-04-03       Impact factor: 5.588

8.  Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1.

Authors:  Toshiki Kijima; Fumitaka Koga; Yasuhisa Fujii; Soichiro Yoshida; Manabu Tatokoro; Kazunori Kihara
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

9.  Clinical significance of HIF-2α immunostaining area in radioresistant cervical cancer.

Authors:  Min Kyu Kim; Tae-Joong Kim; Chang-Ohk Sung; Chel Hun Choi; Jeong-Won Lee; Duk-Soo Bae; Byoung-Gie Kim
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

10.  Effect of Ku70 expression on radiosensitivity in renal carcinoma 786-O cells.

Authors:  Defeng Qi; Yuan Hu; Yangde Zhang; Tao Peng; Weidong Ji
Journal:  Cancer Cell Int       Date:  2014-05-26       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.